Idiopathic Perifoveal Telangiectasis is commonly referred to as macular telangiectasia, a retinal disorder that affects the center most part of the macula. This poorly understood disease is most common in people between 40 to 60 years old. Dilated and leaky retinal capillaries develop around the temporal part of the foveal area and may eventually encompass the entire area, causing pigmentation to migrate below the retina and into the vitreoretinal interface. As this progresses, visual clarity decreases.
Dr. Freund is everything one would want in a doctor: conscientious, ethical, knowledgeable, and experienced. He is ready, able and willing to explain to you your diagnosis and treatment. He’s also very personable. Highly recommended.JOHN G. Google
Unfortunately, there are no known treatments that have been successful in treating idiopathic perifoveal telangiectasia, but in certain cases, injection of anti-VEGF agents, such as Bevacizumab (Avastin), Lucentis, or Eylea may be beneficial.
Let us help you enjoy your lifeCall: (212) 861-9797
To Speak With An Appointment Coordinator Now